tiprankstipranks
Kalaris Therapeutics (KLRS)
NASDAQ:KLRS
US Market

Compare Kalaris Therapeutics (KLRS) vs. Competitors

374 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Kalaris Therapeutics
$6.30
$132.07M
-2.97
-13.82%
1 Buy
1 Hold
0 Sell
Moderate Buy
Coherus Biosciences
$1.68
$251.82M
-1.00
126.42%
4 Buy
0 Hold
0 Sell
Strong Buy
Nektar Therapeutics
$77.50
$2.22B
-5.95
935.27%
7 Buy
1 Hold
0 Sell
Strong Buy
Cellectis SA
$3.59
$270.40M
-4.62
191.87%
1 Buy
1 Hold
0 Sell
Moderate Buy
Seres Therapeutics
$8.32
$79.76M
-2.15
-28.35%
1 Buy
1 Hold
0 Sell
Moderate Buy
Kodiak Sciences
$43.11
$2.62B
-6.56
1957.76%
6 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
KLRS
Kalaris Therapeutics
6.30
-0.58
-8.43%
CHRS
Coherus Biosciences
1.68
0.71
72.48%
NKTR
Nektar Therapeutics
77.50
68.44
755.60%
CLLS
Cellectis SA
3.59
2.09
139.33%
MCRB
Seres Therapeutics
8.32
-4.95
-37.28%
KOD
Kodiak Sciences
43.11
40.93
1877.52%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts